Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4-hydroxy-3-(3-oxo-1-phenylbutyl)-2h-1-benzopyran-2-one
2. Aldocumar
3. Apo-warfarin
4. Coumadin
5. Coumadine
6. Gen-warfarin
7. Marevan
8. Potassium, Warfarin
9. Sodium, Warfarin
10. Tedicumar
11. Warfant
12. Warfarin
13. Warfarin Sodium
1. Potassium Warfarin
2. 2610-86-8
3. Warfarin-potassium
4. Athrombin-k
5. Warfarin-potassium [iso]
6. 3-(alpha-acetonylbenzyl)-4-hydroxycoumarin Potassium Salt
7. I47iu4foco
8. 2h-1-benzopyran-2-one, 4-hydroxy-3-(3-oxo-1-phenylbutyl)-, Potassium Salt
9. Antrombin K
10. Warfarin K
11. Dsstox_cid_22324
12. Dsstox_rid_79995
13. Dsstox_gsid_42324
14. Warfarin Potassium [jan]
15. Cas-2610-86-8
16. Ncgc00094810-04
17. Unii-i47iu4foco
18. Warfarin Potassium [usp:jan]
19. Athrombin-k (tn)
20. Glucoheptonicacid
21. Warfarin Potassium (jp17)
22. Schembl36363
23. Chembl1200772
24. Dtxsid5042324
25. Warfarin Potassium [who-dd]
26. Tox21_111637
27. Coumarin, 3-(alpha-acetonylbenzyl)-4-hydroxy-, Potassium Salt
28. Tox21_111637_1
29. Warfarin Potassium [orange Book]
30. D01280
31. Q27280410
32. Potassium;2-oxo-3-(3-oxo-1-phenylbutyl)chromen-4-olate
33. 3-(.alpha.-acetonylbenzyl)-4-hydroxycoumarin Potassium Salt
Molecular Weight | 346.4 g/mol |
---|---|
Molecular Formula | C19H15KO4 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 4 |
Exact Mass | 346.06074044 g/mol |
Monoisotopic Mass | 346.06074044 g/mol |
Topological Polar Surface Area | 66.4 Ų |
Heavy Atom Count | 24 |
Formal Charge | 0 |
Complexity | 508 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Anticoagulants
Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)
Rodenticides
Substances used to destroy or inhibit the action of rats, mice, or other rodents. (See all compounds classified as Rodenticides.)
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 31512
Submission : 2017-04-11
Status : Inactive
Type : II
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Potassium Warfarin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Potassium Warfarin, including repackagers and relabelers. The FDA regulates Potassium Warfarin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Potassium Warfarin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Potassium Warfarin supplier is an individual or a company that provides Potassium Warfarin active pharmaceutical ingredient (API) or Potassium Warfarin finished formulations upon request. The Potassium Warfarin suppliers may include Potassium Warfarin API manufacturers, exporters, distributors and traders.
click here to find a list of Potassium Warfarin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Potassium Warfarin DMF (Drug Master File) is a document detailing the whole manufacturing process of Potassium Warfarin active pharmaceutical ingredient (API) in detail. Different forms of Potassium Warfarin DMFs exist exist since differing nations have different regulations, such as Potassium Warfarin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Potassium Warfarin DMF submitted to regulatory agencies in the US is known as a USDMF. Potassium Warfarin USDMF includes data on Potassium Warfarin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Potassium Warfarin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Potassium Warfarin suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Potassium Warfarin Drug Master File in Japan (Potassium Warfarin JDMF) empowers Potassium Warfarin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Potassium Warfarin JDMF during the approval evaluation for pharmaceutical products. At the time of Potassium Warfarin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Potassium Warfarin suppliers with JDMF on PharmaCompass.
Potassium Warfarin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Potassium Warfarin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Potassium Warfarin GMP manufacturer or Potassium Warfarin GMP API supplier for your needs.
A Potassium Warfarin CoA (Certificate of Analysis) is a formal document that attests to Potassium Warfarin's compliance with Potassium Warfarin specifications and serves as a tool for batch-level quality control.
Potassium Warfarin CoA mostly includes findings from lab analyses of a specific batch. For each Potassium Warfarin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Potassium Warfarin may be tested according to a variety of international standards, such as European Pharmacopoeia (Potassium Warfarin EP), Potassium Warfarin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Potassium Warfarin USP).
LOOKING FOR A SUPPLIER?